Back to Ophthalmology
Ophthalmologyv2023Evidence-Based

Visual Acuity Testing (Snellen Chart)

Assesses binocular and monocular visual acuity using standardized Snellen optotypes. This test evaluates the clarity of vision by determining the smallest line of letters a patient can accurately read on a standardized chart at a specific distance. Visual acuity testing is a fundamental component of ophthalmologic and neurologic examinations, particularly for cranial nerve II (optic nerve) assessment.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
visual acuity
—fraction
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Visual Acuity Testing (Snellen Chart) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within ophthalmology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Visual acuity = Testing distance / Distance at which normal eye can read the same line. Standard notation: 20/X where X is the denominator corresponding to the smallest line read correctly.

Clinical Pearls & Practice Notes

  • Test each eye independently with the opposite eye covered
  • Ensure proper lighting and standardized testing distance
  • Visual acuity worse than 20/25 warrants professional ophthalmologic evaluation
  • Sudden changes in visual acuity require urgent evaluation
  • This test does not replace comprehensive eye examination
  • Mobile/smartphone testing should use 4-foot distance with maximum screen brightness
  • For patients over 40, presbyopia may affect near vision testing accuracy
  • If unable to read letters, test counting fingers, hand motion, light perception, and no light perception in sequence
  • Results should be documented as corrected or uncorrected visual acuity
  • Standard Snellen optotypes include letters C, D, E, F, L, O, P, T, and Z

Evidence & Literature Citations

  1. Snellen H. Probebuchstaben zur Bestimmung der Sehschärfe. Utrecht: Van de Weijer; 1862.
  2. Elliott DB. The good (logMAR), the bad (Snellen) and the ugly (BCVA, number of letters read) of visual acuity measurement. Ophthalmic Physiol Opt. 2016;36(4):355-358. doi: 10.1111/opo.12310
  3. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5
  4. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53(11):740-745. doi: 10.1097/00006324-197611000-00006

Score Interpretation Ranges

Normal20/20 – 20/20 pts

Normal visual acuity

Mild Impairment20/25 – 20/40 pts

Mild visual impairment

Moderate Impairment20/50 – 20/100 pts

Moderate visual impairment

Severe Impairment20/125 – 20/200 pts

Severe visual impairment approaching legal blindness

Profound ImpairmentCF – NLP pts

Profound visual impairment

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.